Lipigon Pharmaceuticals
0,089
SEK
+1,14 %
Mindre end 1K følgere
LPGO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
+1,14%
-12,21%
+4,76%
+0,04%
-33,96%
-60,4%
-94,56%
-
-98,44%
Lipigon Pharmaceuticals operates in the pharmaceutical industry. The company specializes in the research and development of various drug candidates. The product portfolio is broad and includes drugs for rare diseases. These are mainly treatments for diseases caused by disorders in the body's handling of fats. In addition to the main business, service and associated ancillary services are also offered. Lipigon Pharmaceuticals operates worldwide, with the largest presence in the Nordic market.
Læs mereMarkedsværdi
49,94 mio. SEK
Aktieomsætning
167,11 t SEK
Omsætning
10,29 mio.
EBIT %
-248,59 %
P/E
-
Udbytteafkast, %
-
Finanskalender
26.6
2025
Generalforsamling '25
26.8
2025
Delårsrapport Q2'25
20.11
2025
Delårsrapport Q3'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Redeye: Lipigon Q4 2024 - Rights issue funds 2025
Lipigon Pharmaceuticals' commercial partner announces positive results from Phase I clinical trial with Lipisense
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools